HMC's NCCCR launches home treatment service for cancer patients

Doha, Qatar: Hamad Medical Corporation s National Center for Cancer Care and Research (NCCCR) has launched a new treatment service for Qatari patients...

Doha, Qatar: Hamad Medical Corporation's National Center for Cancer Care and Research (NCCCR) has launched a new treatment service for Qatari patients with prostate and breast cancers.

Through the new service, patients will be given the prescribed chemotherapy injections at home on the scheduled dates according to the treatment plan by a trained nursing team affiliated with NCCCR.

Speaking to Qatar News Agency (QNA), Dr. Mohammed Salem Al Hassan, CEO and Medical Director of NCCCR and Chairman Corporate Cancer Services at HMC, explained that the service was launched at the beginning of Ramadan, based on Qatar Cancer Plan 2023-2026 (QCP) which includes the provision of homecare services for some cancer patients.

Dr. Al Hassan noted that the home treatment service will be provided to bedridden patients, patients over the age of 65, or patients who cannot reach the hospital to receive treatment. Those patients will receive treatment at home and not just care.

Dr. Al Hassan added that a medical team consisting of doctors and nurses has been allocated to visit the patient at his home and evaluate the condition to provide injection treatment at home; noting that the home treatment service is provided every Saturday.